Abbvie Inc (NYSE: ABBV) on Friday, plunged -0.95% from the previous trading day, before settling in for the closing price of $189.65. Within the past 52 weeks, ABBV’s price has moved between $135.85 and $199.95.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 11.76%. The company achieved an average annual earnings per share of -2.32%. With a float of $1.76 billion, this company’s outstanding shares have now reached $1.77 billion.
The extent of productivity of a business whose workforce counts for 50000 workers is very important to gauge. In terms of profitability, gross margin is 72.49%, operating margin of 27.0%, and the pretax margin is 12.85%.
Abbvie Inc (ABBV) Insider and Institutional Ownership
Observing investor behavior towards Drug Manufacturers – General industry stocks is more important than anything else. The insider ownership of Abbvie Inc is 0.09%, while institutional ownership is 73.03%. The most recent insider transaction that took place on Aug 08 ’24, was worth 9,297,210. Before that another transaction happened on Aug 05 ’24, when Company’s EXECUTIVE CHAIRMAN OF BOARD sold 66,500 for $186.52, making the entire transaction worth $12,403,580. This insider now owns 446,599 shares in total.
Abbvie Inc (ABBV) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -2.32% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.75% during the next five years compared to -5.77% drop over the previous five years of trading.
Abbvie Inc (NYSE: ABBV) Trading Performance Indicators
Abbvie Inc (ABBV) is currently performing well based on its current performance indicators. A quick ratio of 0.71 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.03. Likewise, its price to free cash flow for the trailing twelve months is 18.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.99, a number that is poised to hit 2.91 in the next quarter and is forecasted to reach 12.10 in one year’s time.
Technical Analysis of Abbvie Inc (ABBV)
The latest stats from [Abbvie Inc, ABBV] show that its last 5-days average volume of 4.75 million was inferior to 5.29 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 24.65%. Additionally, its Average True Range was 2.86.
During the past 100 days, Abbvie Inc’s (ABBV) raw stochastic average was set at 67.98%, which indicates a significant increase from 18.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 14.12% in the past 14 days, which was lower than the 18.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $193.97, while its 200-day Moving Average is $177.05. Now, the first resistance to watch is $189.43. This is followed by the second major resistance level at $191.01. The third major resistance level sits at $192.14. If the price goes on to break the first support level at $186.72, it is likely to go to the next support level at $185.59. The third support level lies at $184.01 if the price breaches the second support level.
Abbvie Inc (NYSE: ABBV) Key Stats
Market capitalization of the company is 331.81 billion based on 1,765,868K outstanding shares. Right now, sales total 54,318 M and income totals 4,863 M. The company made 14,462 M in profit during its latest quarter, and 1,370 M in sales during its previous quarter.
